Litigation Details for AstraZeneca AB v. Sun Pharmaceutical Industries Limited (D. Del. 2023)
✉ Email this page to a colleague
AstraZeneca AB v. Sun Pharmaceutical Industries Limited (D. Del. 2023)
| Docket | ⤷ Sign Up | Date Filed | 2023-12-04 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:1 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 6,515,117 | ||
| Link to Docket | External link to docket | ||
Details for AstraZeneca AB v. Sun Pharmaceutical Industries Limited (D. Del. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-12-04 | 1 | Complaint | ”), prior to expiration of U.S. Patent No. 6,515,117 (“the ’117 patent”). … This is an action for patent infringement arising under the patent laws of the United States, … 39. The ’117 patent expires on October 4, 2025, inclusive of patent term extension under 35… to the ’117 patent. 45. Sun thus has actual knowledge of the ’117 patent. 46.… ) COMPLAINT FOR PATENT INFRINGEMENT Plaintiff AstraZeneca AB | External link to document |
| 2023-12-04 | 3 | ANDA Form | October 20, 2023. Date of Expiration of Patent: October 4, 2025 (6,515,117). Thirty Month Stay Deadline: No … Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 4 December 2023 1:23-cv-01381 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2023-12-04 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,515,117. (twk) (Entered: 12… 4 December 2023 1:23-cv-01381 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
